A Food and Drug Administration analysis released Tuesday found the blood thinner Pradaxa was better at avoiding strokes and brain hemorrhage than a decades-old alternative, though it was linked to more stomach bleeding.. The findings help alleviate some safety concerns about Pradaxa, a drug from Boehringer Ingelheim GmbH. But the bleeding risk has been the subject of thousands of lawsuits, and the study doesn't eliminate existing concerns about that risk.